Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.470
-0.140 (-8.70%)
At close: Nov 20, 2024, 4:00 PM
1.480
+0.010 (0.68%)
After-hours: Nov 20, 2024, 7:38 PM EST
Akari Therapeutics, Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 18 | 18 | 35 | 71 | 71 | 37 | |
| Market Cap Growth | 76.39% | -49.58% | -51.00% | 0.31% | 93.60% | 48.15% | |
| Enterprise Value | 16 | 10 | 27 | 58 | 59 | 30 | |
| Last Close Price | 1.47 | 3.12 | 9.40 | 30.00 | 37.00 | 35.00 | |
| PB Ratio | -5.27 | -77.02 | 19.53 | 12.85 | 7.58 | 4838.79 | |
| P/TBV Ratio | - | - | 19.72 | 12.91 | 7.61 | - | |
| Debt / Equity Ratio | -0.15 | - | - | - | - | - | |
| Quick Ratio | 0.24 | 0.84 | 1.10 | 1.54 | 2.69 | 0.89 | |
| Current Ratio | 0.29 | 0.95 | 1.15 | 1.91 | 2.79 | 1.00 | |
| Return on Equity (ROE) | - | -1281.43% | -483.23% | -233.27% | -363.75% | -1080.27% | |
| Return on Assets (ROA) | -307.55% | -115.51% | -113.27% | -81.96% | -106.60% | -146.14% | |
| Return on Capital (ROIC) | - | -1344.91% | -392.89% | -144.04% | -239.31% | -679.86% | |
| Earnings Yield | -114.71% | -56.74% | -50.73% | -24.41% | -24.00% | -45.82% | |
| FCF Yield | -84.44% | -93.17% | -61.47% | -26.40% | -23.81% | -35.14% | |
| Buyback Yield / Dilution | -86.15% | -56.79% | -45.46% | -35.87% | -72.53% | -18.87% | |
| Total Shareholder Return | -86.15% | -56.79% | -45.46% | -35.87% | -72.53% | -18.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.